Chris Potter / Flickr Creative Commons

The latest drug pricing controversy comes from Marathon Pharmaceuticals, a company that received federal approval Thursday for an old drug, deflazacort, to treat patients who are at least 5 years old and have the rare Duchenne muscular dystrophy.

The Wall Street Journal and others reported the annual list price will be $89,000. Wanda Moebius, a spokesperson for Marathon, told Axios the net annual amount that Marathon will receive after rebates and discounts will be closer to $54,000 on average.

Here's the catch: Marathon's deflazacort, a steroid, was already approved outside of the United States and can be bought for a lot less. The drug can be bought for less than $2,000 annually from the United Kingdom or Canada. Moebius justified the U.S. price, saying Marathon "can only sell the drug in the U.S. in this population." She added, "Anyone who needs this drug will get this drug."

Why this matters: Marathon's drug will get seven years of monopoly pricing, among other perks for so-called orphan drugs. That's raised the ire of many, who believe this is just another example of egregious drug pricing policy. Rachel Sachs, a law professor at Washington University in St. Louis, put Marathon's move this way:

"This is not acceptable. Full stop. It is the worst sort of gaming that other companies have engaged in over the years."

Go deeper

Trump commutes Roger Stone's sentence

Roger Stone arriving at his sentencing hearing on Feb. 20. Photo: Drew Angerer/Getty Images

President Trump on Friday evening commuted the sentence of his longtime associate Roger Stone, according to two senior administration officials. Stone in February was sentenced to 40 months in prison for crimes including obstruction, witness tampering and making false statements to Congress.

Why it matters: The controversial move brings an abrupt end to the possibility of Stone spending time behind bars. He had been scheduled to report to prison on July 14.

Updated 10 hours ago - Health

Which states have set single-day coronavirus records this week

Data: COVID Tracking Project and state health department data compiled by Axios; Map: Danielle Alberti and Naema Ahmed/Axios

13 states this week surpassed records set just last week for their highest number of coronavirus infections in a single day, according to the COVID Tracking Project and state health department data. 16 states in total reported new highs.

The big picture: The United States' alarming rise in coronavirus cases isn't just due to increased testing — particularly where the number of cases has grown fastest over the last month, Axios' Andrew Witherspoon and Caitlin Owens report.

Updated 10 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Sarah Grillo/Axios

  1. Global: Total confirmed cases as of 6:30 p.m. ET: 12,389,660 — Total deaths: 557,279 — Total recoveries — 6,830,596Map.
  2. U.S.: Total confirmed cases as of 6:30 p.m. ET: 3,169,611 — Total deaths: 133,885 — Total recoveries: 983,185 — Total tested: 38,856,341Map.
  3. Public health: The reality of the coronavirus bites.
  4. Trade: Trump says he's no longer considering phase-two trade deal with China because the pandemic damaged the two countries' relationship.
  5. 🎧 Podcast: Rural America has its own coronavirus problem.